Alpha Growth PLC Acquisition and Insurance Business Update (8064F)

TIDMALGW

RNS Number : 8064F

Alpha Growth PLC

24 March 2022

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as in force in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018). Upon the publication of this announcement, this inside information is now considered to be in the public domain

Alpha Growth Plc

("Alpha", or the "Company")

Acquisition and Insurance Business Update

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing longevity asset class, is very pleased to announce that its Bermuda subsidiary has signed a share purchase agreement to acquire a Guernsey based life insurance company. This transaction advances Alpha's acquisition strategy of consolidating life insurance companies and represents a significant step towards achieving Alpha Growth's goal of managing over $2bn of assets by 2025.

Acquisition

The Guernsey based insurance company is a Category 1, international life insurer, with approximately 3,785 long-term life insurance contracts in force as of 31 December 2021.

The acquisition has a transaction value of $3.3m and includes all operations of the company, including its assets under management of approximately $370m as valued at 31 December 2021. The business is being acquired from a major international insurance group.

This acquisition more than doubles Alpha's assets under management and provides an excellent platform for Alpha to offer both life insurance-based wealth management products and life insurance linked funds, either originated by Alpha or through other partners.

Additionally, the life insurance company provides a good European based platform for further acquisitions. All activities are subject to regulatory approval and oversight.

The Directors of the Company's subsidiary Providence Life Assurance Company (Bermuda) Ltd (Gobind Sahney, Jason Sutherland, and Dan Gray) will be joining the acquired company's board.

The acquisition is subject to the approval of the relevant regulatory authorities and is expected to complete sometime mid-year. Further updates and information will be provided in due course.

The Company is funding the acquisition from operations, and it will not require an equity raise.

Delivering on The 2B Plan

This acquisition is a key building block in delivering upon the Company's previously announced 2B Plan. The 2B plan is Alpha's strategy to be managing over $2bn of assets by 2025.

Once the acquisition is completed, the Company's aggregated assets under management will be over $700m. This provides the Company with a substantial source of predictable, sticky and recurring revenue and represents a 70 fold increase in AUM from the $10m that the Company reported in January 2020.

With this acquisition, and taking into consideration the excellent prospects of both Alpha's Fund and its Insurance segments, the Directors have decided to concentrate the Company's focus on these two key segments. By focusing on these two key segments, it allows the Company to direct its resources and human capital efficiently to ensure that maximum growth and shareholder returns are achieved.

As a result, the Company will be ceasing discussions with counterparties in regards to separate managed accounts, revolving credit facilities, and other esoteric AUM building activities. Whilst these activities would have increased AUM, the Company has other prospects which provide better returns and which require less overhead.

This refocusing of activities creates a strong and simpler proposition with substantial value creation opportunities - the focus for 2022 will be to continue to aggressively expand both the fund and insurance segments.

The BlackOak Alpha Growth Fund has grown from $10m to over $50m since 2020 and once the acquisition is completed the insurance segment will have grown from zero to over $650m.

Additionally, the Company's subsidiary Providence Life Assurance Company, as part of the insurance segment, also issued its first policy since it became part of the Group for a $5m committed premium this month and continues to expand its plan of distribution for its policies through registered investment advisors and other professionals that advise ultra-high net worth individuals and family offices on PPLI.

The Company continues to have a very strong pipeline of opportunities across both segments and we are very confident that these opportunities will drive significant increases in AUM and the associated fees. We expect to make further announcements in due course.

Gobind Sahney, Executive Chairman, commented "This acquisition is another key building block in our plan to be managing over $2bn of assets by 2025 and I'm very pleased to announce that we are currently tracking ahead of schedule to achieve that aim."

Gobind continued, "This acquisition not only increases our AUM substantially, it also provides us with the ability to offer very tax efficient insurance based wealth management products and will also serve as a European vehicle for further value accretive acquisitions."

Alpha Growth will be responding to shareholder questions by the end of this month and shall be announcing its end of year accounts by the end of April.

For more information, please visit www.algwplc.com or contact the following:

 
                Alpha Growth Plc                                           [phone] 
                Gobind Sahney, Executive Chairman                          [e-mail] 
 
                Arden Partners plc                                         [phone] 
                Ruari McGirr / Alexandra Campbell-Harris 
                 (Corporate Finance) 
 
                UK Investor Relations - Mark Treharne                      [e-mail] 
 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

Important Notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQKZGZFKFMGZZM

(END) Dow Jones Newswires

March 24, 2022 03:00 ET (07:00 GMT)